KESTRA PRIVATE WEALTH SERVICES, LLC - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
KESTRA PRIVATE WEALTH SERVICES, LLC ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$30,000
-33.3%
29,000
+20.8%
0.00%0.0%
Q1 2022$45,000
-22.4%
24,000
+100.0%
0.00%
-33.3%
Q4 2021$58,00012,0000.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders